Universal Beteiligungs und Servicegesellschaft mbH Has $174.22 Million Position in Danaher Corporation $DHR

Universal Beteiligungs und Servicegesellschaft mbH decreased its holdings in shares of Danaher Corporation (NYSE:DHR) by 4.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 878,738 shares of the conglomerate’s stock after selling 36,401 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Danaher were worth $174,219,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. WFA of San Diego LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in shares of Danaher during the 2nd quarter valued at $27,000. TruNorth Capital Management LLC bought a new position in Danaher during the third quarter worth $28,000. Red Tortoise LLC grew its holdings in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Finally, Tripletail Wealth Management LLC bought a new stake in Danaher in the third quarter valued at $31,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 0.8%

NYSE:DHR opened at $234.11 on Wednesday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The firm has a 50-day moving average price of $229.17 and a two-hundred day moving average price of $212.44. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $165.36 billion, a price-to-earnings ratio of 48.27, a price-to-earnings-growth ratio of 4.20 and a beta of 0.89.

Danaher (NYSE:DHR) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the company posted $1.71 earnings per share. Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. On average, equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s payout ratio is presently 26.39%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on DHR shares. Rothschild Redb downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. TD Cowen boosted their price objective on Danaher from $260.00 to $270.00 and gave the company a “buy” rating in a report on Wednesday, January 7th. HSBC upped their target price on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Finally, Wells Fargo & Company lifted their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Twenty-one research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $251.87.

Insider Transactions at Danaher

In related news, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,248 shares of company stock worth $6,609,663 in the last ninety days. Company insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.